| Treatment adherence and clinical outcomes amongst in people with drug-susceptible tuberculosis using medication monitor and differentiated care approach compared with standard … S Charalambous, N Maraba, L Jennings, I Rabothata, D Cogill, R Mukora, ... eClinicalMedicine 75, 2024 | | 2024 |
| Can resistance testing improve outcomes for children and adolescents with HIV? JH Levison, C Orrell The Lancet Global Health 12 (8), e1219-e1220, 2024 | | 2024 |
| A prospective randomised controlled trial investigating household SARS-CoV-2 transmission in a densely populated community in Cape Town, South Africa–the transmission of COVID … P Smith, F Little, S Hermans, MA Davies, R Wood, C Orrell, C Pike, ... BMC Public Health 24 (1), 1924, 2024 | | 2024 |
| Clinical, pharmacological, and qualitative characterization of drug–drug interactions in pregnant women initiating HIV therapy in Sub-Saharan Africa D Kiiza, D Rostami-Hochaghan, Y Alhassan, K Seden, H Reynolds, ... Journal of Antimicrobial Chemotherapy, dkae232, 2024 | | 2024 |
| Multilevel strategies to end HIV for young couples in Cape Town: Study protocol for a cluster randomized trial WM Wechsberg, T Carney, FA Browne, IM van der Drift, TL Kline, ... Plos one 19 (6), e0305056, 2024 | | 2024 |
| Switch to fixed-dose doravirine (100 mg) with islatravir (0· 75 mg) once daily in virologically suppressed adults with HIV-1 on antiretroviral therapy: 48-week results of a … JM Molina, G Rizzardini, C Orrell, A Afani, A Calmy, S Oka, F Hinestrosa, ... The Lancet HIV 11 (6), e369-e379, 2024 | 3 | 2024 |
| Negative clinic experiences as a barrier to care for people with HIV and their impact on patient preferences for intervention support: a qualitative study in Cape Town, South … C Killian, RL West, C Orrell, A Gifford, JE Haberer, N Halim, L Jennings, ... AIDS care, 1-10, 2024 | | 2024 |
| Baseline determinants of adherence for drug-sensitive TB treatment in a South African prospective cohort: a focus on HIV infection and anti-retroviral therapy, clinical care … A Steulet, P Hippner, N Maraba, L Jennings, I Rabothata, R Mukora, ... | | 2024 |
| Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials DB Reeves, BT Mayer, AC deCamp, Y Huang, B Zhang, LN Carpp, ... nature communications 15 (1), 2575, 2024 | | 2024 |
| Social networks and HIV treatment adherence among people with HIV initiating treatment in rural Uganda and peri-urban South Africa AB Comfort, S Asiimwe, G Amaniyre, C Orrell, J Moody, N Musinguzi, ... SSM-Population Health 25, 101593, 2024 | | 2024 |
| Reactivation of Kaposi’s sarcoma-associated herpesvirus (KSHV) by SARS-CoV-2 in non-hospitalised HIV-infected patients H Lambarey, MJ Blumenthal, A Chetram, W Joyimbana, L Jennings, ... EBioMedicine 100, 2024 | 3 | 2024 |
| Safety and efficacy of doravirine as first-line therapy in adults with HIV-1: week 192 results from the open-label extensions of the DRIVE-FORWARD and DRIVE-AHEAD phase 3 trials C Orkin, JM Molina, P Cahn, J Lombaard, K Supparatpinyo, S Kumar, ... The Lancet HIV 11 (2), e75-e85, 2024 | 3 | 2024 |
| High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials DB Reeves, BT Mayer, AC Decamp, Y Huang, B Zhang, LN Carpp, ... Nature Communications 14 (1), 8299, 2023 | 2 | 2023 |
| PA-613 Early identification of ART missed doses: baseline data from the RETAIN study C Orrell, L Jennings, C Schreuder, R Madimabe, T Mosina, L Sabin BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
| OA-102 Reactivation of oncogenic herpesviruses is associated with co-infections causing severe inflammatory presentations in HIV-infected patients from Gugulethu, South Africa G Schafer, H Lambarey, M Blumenthal, A Chetram, W Joyimbana, ... BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
| PA-727 Physiologically-based pharmacokinetic modelling of drug-drug interactions between ritonavir-boosted atazanavir and rifampicin in pregnancy S Atoyebi, MC Montanha, L Najjemba, C Orrell, L Jennings, H Mugerwa, ... BMJ Global Health 8 (Suppl 10), 2023 | | 2023 |
| Acceptability of using the medication monitor and experience of a differentiated care approach for TB treatment adherence among people living with TB in South Africa R Mukora, B Ahumah, N Maraba, C Orrell, L Jennings, P Naidoo, ... PLOS Global Public Health 3 (10), e0001885, 2023 | 3 | 2023 |
| Perspectives of people living with HIV and health workers about a point-of-care adherence assay: a qualitative study on acceptability A Mcinziba, D Wademan, L Viljoen, H Myburgh, L Jennings, E Decloedt, ... AIDS care 35 (10), 1628-1634, 2023 | 7 | 2023 |
| Acceptability and feasibility of providing adherence feedback based on tenofovir diphosphate in dried blood spots: results from a Pilot study among patients and providers in … CM Ferraris, PA D’avanzo, L Jennings, RN Robbins, N Nguyen, CS Leu, ... AIDS and Behavior 27 (10), 3478-3486, 2023 | 2 | 2023 |
| Reactivation of Latent Kaposi's Sarcoma-Associated Herpesvirus (KSHV) by SARS-CoV-2 in Non-Hospitalised HIV-Infected Patients H Lambarey, MJ Blumenthal, A Chetram, W Joyimbana, L Jennings, ... Available at SSRN 4583146, 2023 | | 2023 |
